Different effects of prolonged β-adrenergic stimulation on heart and cerebral artery

Esler, 1986, Mechanism of elevated plasma noradrenaline in the course of essential hypertension, J Cardiovasc Pharmacol, 8, S39, 10.1097/00005344-198608005-00008 Esler, 2008, Neural mechanisms and management of obesity-related hypertension, Curr Cardiol Rep, 10, 456, 10.1007/s11886-008-0072-7 Narkiewicz, 1999, Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea, Circulation, 99, 1183, 10.1161/01.CIR.99.9.1183 Neumann, 2005, White-coat hypertension and autonomic nervous system dysregulation, Am J Hypertens, 18, 584, 10.1016/j.amjhyper.2004.11.034 Davis, 1993, Brain–heart interactions. The neurocardiology of arrhythmia and sudden cardiac death, Tex Heart Inst J, 20, 158 Dunn, 1993, Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy, J Hypertens, 11, 1003, 10.1097/00004872-199310000-00002 Hart, 1994, Cellular electrophysiology in cardiac hypertrophy and failure, Cardiovasc Res, 28, 933, 10.1093/cvr/28.7.933 Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203 Osadchii, 2007, Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects, Heart Fail Rev, 12, 66, 10.1007/s10741-007-9007-4 Lechat, 1998, Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials, Circulation, 98, 1184, 10.1161/01.CIR.98.12.1184 Bristow, 1996, Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators, Circulation, 94, 2807, 10.1161/01.CIR.94.11.2807 Davis, 2002, Ann Intern Med, 137, 313, 10.7326/0003-4819-137-5_Part_1-200209030-00006 Devereaux, 2008, Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, Lancet, 371, 1839, 10.1016/S0140-6736(08)60601-7 Kim, 2003, Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy, Circ Res, 93, 541, 10.1161/01.RES.0000090087.66390.F2 Kim, 2006, Site specific differential activation of ras/raf/ERK signaling in rabbit isoproterenol-induced left ventricular hypertrophy, Biochim Biophys Acta, 1763, 1067, 10.1016/j.bbamcr.2006.08.002 Zheng, 2005, Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling, Pharmacol Ther, 108, 257, 10.1016/j.pharmthera.2005.04.006 Diwan, 2007, Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets, Physiology (Bethesda), 22, 56, 10.1152/physiol.00033.2006 Gupta, 2007, Cardiac hypertrophy: mechanisms and therapeutic opportunities, Antioxid Redox Signal, 9, 623, 10.1089/ars.2007.1474 Kang, 2006, Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death, Toxicol Pathol, 34, 58, 10.1080/01926230500419421 Errami, 2008, Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice, J Pharmacol Exp Ther, 324, 1196, 10.1124/jpet.107.133975 Freund, 2005, Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo, Circulation, 111, 2319, 10.1161/01.CIR.0000164237.58200.5A Hanada, 2008, Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers, Eur J Pharmacol, 589, 194, 10.1016/j.ejphar.2008.04.055 Metrich, 2008, Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy, Circ Res, 102, 959, 10.1161/CIRCRESAHA.107.164947 Molojavyi, 2010, Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy, Physiol Genomics, 41, 137, 10.1152/physiolgenomics.90297.2008 Hayes, 1986, Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists, J Pharmacol Exp Ther, 237, 757 Tse, 1979, Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of beta-adrenergic receptor, adenylate cyclase, and ventricular contraction, Endocrinology, 105, 246, 10.1210/endo-105-1-246 Choi, 1997, Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase, J Biol Chem, 272, 17223, 10.1074/jbc.272.27.17223 Iaccarino, 1998, Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade, Circulation, 98, 1783, 10.1161/01.CIR.98.17.1783 Contard, 1993, Diuretic effects on cardiac hypertrophy in the stroke prone spontaneously hypertensive rat, Cardiovasc Res, 27, 429, 10.1093/cvr/27.3.429 Rodrigo, 2012, Addressing the relationship between cardiac hypertrophy and ischaemic stroke: an observational study, Int Arch Med, 5, 5, 10.1186/1755-7682-5-32 Chruscinski, 2001, Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors, Mol Pharmacol, 60, 955, 10.1124/mol.60.5.955 Park, 2007, Increased inhibition of inward rectifier K+ channels by angiotensin II in small-diameter coronary artery of isoproterenol-induced hypertrophied model, Arterioscler Thromb Vasc Biol, 27, 1768, 10.1161/ATVBAHA.107.143339 Davel, 2006, Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation, Br J Pharmacol, 148, 629, 10.1038/sj.bjp.0706749 Davel, 2014, Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gialpha-coupled beta2-adrenoceptor signaling pathway, PLoS One, 9, e91877, 10.1371/journal.pone.0091877 Kim, 2012, Beta adrenergic overstimulation impaired vascular contractility via actin-cytoskeleton disorganization in rabbit cerebral artery, PLoS One, 7, e43884, 10.1371/journal.pone.0043884 Dragunow, 1995, The role of inducible transcription factors in apoptotic nerve cell death, Brain Res Brain Res Rev, 21, 1, 10.1016/0165-0173(95)00003-L Hughes, 1995, Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system, Pharmacol Rev, 47, 133 Krown, 1996, Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death, J Clin Invest, 98, 2854, 10.1172/JCI119114 Dzimiri, 2004, Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload, Fundam Clin Pharmacol, 18, 39, 10.1046/j.0767-3981.2003.00212.x Chesley, 2000, The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase, Circ Res, 87, 1172, 10.1161/01.RES.87.12.1172 Schmidt, 2004, PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors, BMC Biol, 2, 12, 10.1186/1741-7007-2-7 Pozzi, 2006, H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis, Mol Biol Cell, 17, 2046, 10.1091/mbc.E05-08-0800 Tanaka, 1999, H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells, J Immunol, 163, 6209, 10.4049/jimmunol.163.11.6209 Zimmer, 1997, Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression, J Mol Med (Berl), 75, 849, 10.1007/s001090050176 Kolch, 2000, Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions, Biochem J, 351, 289, 10.1042/bj3510289 Chen, 2005, PKA independent and cell type specific activation of the expression of caudal homeobox gene Cdx-2 by cyclic AMP, FEBS J, 272, 2746, 10.1111/j.1742-4658.2005.04694.x Kureishi, 1997, Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation, J Biol Chem, 272, 12257, 10.1074/jbc.272.19.12257 Gunst, 2008, Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction, Am J Physiol Cell Physiol, 295, C576, 10.1152/ajpcell.00253.2008 Remiao, 2000, Inhibition of glutathione reductase by isoproterenol oxidation products, J Enzyme Inhib, 15, 47, 10.1080/14756369909030340 Moniri, 2007, Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction, Biochem Pharmacol, 74, 64, 10.1016/j.bcp.2007.03.016 Remondino, 2003, Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway, Circ Res, 92, 136, 10.1161/01.RES.0000054624.03539.B4 Davel, 2008, Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta, Am J Physiol Heart Circ Physiol, 295, H211, 10.1152/ajpheart.00581.2007 Keles, 2009, Investigation of effects of lacidipine, ramipril, and valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats, Mol Cell Biochem, 328, 109, 10.1007/s11010-009-0080-y Herrmann, 2014, Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo, Toxicol Appl Pharmacol, 274, 302, 10.1016/j.taap.2013.11.011 Hong, 2011, Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes, Proteomics, 11, 283, 10.1002/pmic.201000018 Martin, 1997, Small heat shock proteins and protection against ischemic injury in cardiac myocytes, Circulation, 96, 4343, 10.1161/01.CIR.96.12.4343 Corbi, 2013, Adrenergic signaling and oxidative stress: a role for sirtuins?, Front Physiol, 4, 14, 10.3389/fphys.2013.00324 Zha, 1996, Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L), Cell, 87, 619, 10.1016/S0092-8674(00)81382-3 Yasuhara, 2003, Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis, J Histochem Cytochem, 51, 873, 10.1177/002215540305100703 Ratcliffe, 2000, Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis, J Autoimmun, 15, 359, 10.1006/jaut.2000.0432 Park, 2004, Hypertensive left ventricular hypertrophy: relation to beta-adrenergic receptor kinase-1 (betaARK1) in peripheral lymphocytes, J Hypertens, 22, 1025, 10.1097/00004872-200405000-00026